Pulike Biological Engineering, Inc. (SHA:603566)

SHA:603566 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	255.07	137.31	205.26	317.21	281.65	168.83
Trading Asset Securities	545.68	635.85	480.33	407.58	691.36	75
Cash & Short-Term Investments	800.75	773.16	685.59	724.79	973.01	243.83
Cash Growth	0.73%	12.77%	-5.41%	-25.51%	299.05%	-53.03%
Accounts Receivable	395.95	359.81	372.9	464.48	496.32	304.54
Other Receivables	11.13	7.03	6.13	6.19	5.12	4.34
Receivables	407.08	366.85	379.04	470.66	501.44	308.89
Inventory	189.04	219.73	192.6	183.62	191.51	170.56
Other Current Assets	15	7.57	10.33	30.4	17.22	10.15
Total Current Assets	1,412	1,367	1,268	1,409	1,683	733.43
Property, Plant & Equipment	1,162	1,292	1,163	1,175	949.86	651.6
Long-Term Investments	126.4	158.64	304.63	315.51	356.68	391.95
Goodwill	29.29	29.29	17.81	17.81	17.81	17.81
Other Intangible Assets	302.56	303.54	279.18	283.35	286.47	276.08
Long-Term Deferred Tax Assets	8.02	7.89	8.75	7.82	25.16	5.91
Long-Term Deferred Charges	-	0.01	0.58	1.15	1.55	-
Other Long-Term Assets	59.89	78.31	56.14	51.85	74.82	91.5
Total Assets	3,100	3,237	3,097	3,262	3,396	2,168

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	109.73	135.81	128.63	144.94	170.71	48.95
Accrued Expenses	40.49	187.58	227.63	264.73	290.75	207.56
Short-Term Debt	-	-	-	-	7.01	-
Current Portion of Leases	-	6.95	1.08	1	0.81	-
Current Income Taxes Payable	12.38	1.64	0.74	5.2	16.02	6.88
Current Unearned Revenue	63.53	54.73	33.41	23.73	12.56	15.16
Other Current Liabilities	146.53	38.44	42.44	68.43	58.28	67.05
Total Current Liabilities	379.46	425.14	433.93	508.03	556.13	345.59
Long-Term Debt	18.45	18.82	-	-	-	-
Long-Term Leases	0.27	1.47	0.17	1.06	1.87	-
Long-Term Unearned Revenue	24.83	34.02	31.38	21.6	8.26	6.97
Long-Term Deferred Tax Liabilities	20.48	20.55	5.62	7.65	25.29	15.27
Total Liabilities	443.49	500	471.11	538.33	591.56	367.83

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	346.06	346.06	346.06	352.92	352.92	321.5
Additional Paid-In Capital	1,197	1,197	1,197	1,324	1,346	473.21
Retained Earnings	1,066	1,123	1,143	1,188	1,239	1,139
Treasury Stock	-60.34	-60.34	-60.34	-141.19	-133.55	-133.55
Total Common Equity	2,549	2,606	2,626	2,724	2,804	1,800
Minority Interest	107.97	130.92	-	-	-	-
Shareholders' Equity	2,657	2,737	2,626	2,724	2,804	1,800
Total Liabilities & Equity	3,100	3,237	3,097	3,262	3,396	2,168

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	25.52	27.23	1.26	2.05	9.69	-
Net Cash (Debt)	775.23	745.92	684.33	722.74	963.32	243.83
Net Cash Growth	-2.33%	9.00%	-5.31%	-24.97%	295.08%	-53.03%
Net Cash Per Share	2.24	2.18	1.99	2.07	2.98	0.78
Filing Date Shares Outstanding	365.16	341.92	341.92	344.61	346.06	314.64
Total Common Shares Outstanding	365.16	341.92	341.92	345.7	346.06	314.64
Working Capital	1,032	942.17	833.64	901.45	1,127	387.84
Book Value Per Share	6.98	7.62	7.68	7.88	8.10	5.72
Tangible Book Value	2,217	2,273	2,329	2,423	2,500	1,507
Tangible Book Value Per Share	6.07	6.65	6.81	7.01	7.22	4.79
Buildings	-	1,021	954.69	599.48	486.01	370.61
Machinery	-	966.41	700.97	634.4	525.17	397.97
Construction In Progress	-	23.17	9.3	382.75	308.86	205.54

Data Source: S&P Global Market Intelligence Last updated: Oct 26, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 2, 2026

Data Sources Report a data error